1Q 2021 Results May 4, 2021 Charles River Laboratories EVERY STEP OF THE WAY © 2021 Charles River Laboratories International, Inc. Safe Harbor Statement 2 Caution Concerning Forward-Looking Statements. This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "anticipate," "believe," "expect," "intend," "will," "may," "estimate," "plan," "outlook," and "project" an ...

Charles River Laboratories International, Inc. (NYSE:CRL) Q1 2021 Earnings Conference Call May 4, 2021 9:00 AM ET Company Participants Todd Spencer - Corporate Vice President, Investor Relations Jim Foster - Chairman, President & Chief Executive Officer David Smith - Executive Vice President & Chief Financial Officer Conference Call Participants John Kreger - William Blair Eric Coldwell - Baird Dave Windley - Jefferies Robert Jones - Goldman Sachs Tycho Peterson - JPMorgan Ricky Goldwasser - Morgan Stanley ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________ FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED December 26, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File No. 001-15943 charles river CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Exact Name of Registran ...

Charles River Laboratories International, Inc. (NYSE:CRL) Q4 2020 Earnings Conference Call February 17, 2021 8:30 AM ET Company Participants Todd Spencer - Corporate Vice President, Investor Relations Jim Foster - Chairman, President & Chief Executive Officer David Smith - Executive Vice President & Chief Financial Officer Conference Call Participants Eric Coldwell - Baird Dave Windley - Jefferies John Kreger - William Blair Ricky Goldwasser - Morgan Stanley Juan Avendano - Bank of America Robert Jones - ...

| --- | --- | --- | --- | |-------|-------|---------------------|-------| | | | | | | | | | | | | | 4Q 2020 Results and | | | | | | | | | | 2021 Guidance | | | | | February 17, 2021 | | Charles River Laboratories EVERY STEP OF THE WAY © 2021 Charles River Laboratories International, Inc. Safe Harbor Statement 2 Caution Concerning Forward-Looking Statements. This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statem ...

JP Morgan 39th Annual Healthcare Conference January 12, 2021 Charles River Laboratories James C. Foster Chairman, President & Chief Executive Officer EVERY STEP OF THE WAY © 2021 Charles River Laboratories International, Inc. Safe Harbor Statement 2 Caution Concerning Forward-Looking Statements. This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "anticipate, ...

Charles River Laboratories International, Inc. (NYSE:CRL) Q3 2020 Earnings Conference Call October 29, 2020 9:30 AM ET Company Participants Todd Spencer - IR James Foster - Chairman, President & CEO David Smith - CFO Conference Call Participants Dave Windley - Jefferies John Kreger - William Blair Eric Coldwell - Baird Tycho Peterson - JPMorgan Robert Jones - Goldman Sachs Erin Wright - Credit Suisse Elizabeth Anderson - Evercore ISI Juan Avendano - Bank of America Dan Brennan - UBS Patrick Donnelly - Citi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________ FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED December 28, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File No. 001-15943 charles river CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Exact Name of Registran ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________ FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 29, 2018 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File No. 001-15943 charles river CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Exact Name of Registran ...